Due to the biosynthetic processes used to produce biopharmaceuticals, an inherent degree of structural heterogeneity is often present in finished product, meaning the finished product can be a mixture of post-translationally modified forms
Full structural characterization is often required for these products and Almac have a number of tools at their disposal for this:
- High resolution mass spec protein mapping
- Amino acid analysis according to USP 1052
- N- and C- terminal sequence analysis
- De novo sequencing
- Sulfhydryl group and disulfide bond analysis
- Carbohydrate structure analysis
Downloadable summaries are hyperlinked explaining these analytical technologies in more detail.